Drug
Lidocaine
Lidocaine: highest development phase Post-Market, developed by Aurobindo, Endo, Hikma. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Aurobindo, Endo, Hikma
Trials
| Drug | Phase | Indication |
|---|---|---|
| lidocaine NCT01515540 | Post-Market | Low Back Pain |
| LIDOCAINE | Approved | |
| LIDOCAINE HYDROCHLORIDE | Approved |
Latest
- Label updated: LIDOCAINE
- Label updated: LIDOCAINE
- Label updated: LIDOCAINE HYDROCHLORIDE
- Label updated: LIDOCAINE
Follow Lidocaine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.